Form 425 Moringa Acquisition Corp Filed by: Moringa Acquisition Corp
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 17, 2022
MORINGA ACQUISITION CORP
(Exact Name of Registrant as Specified in its Charter)
|(State or other jurisdiction||(Commission File Number)||(I.R.S. Employer|
|of incorporation)||Identification No.)|
|250 Park Avenue, 7th Floor|
|New York, NY||11040|
|(Address of Principal Executive Offices)||(Zip Code)|
Registrant’s telephone number, including area code
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|☒||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
|Units, each consisting of one Class A ordinary share and one-half of a redeemable warrant||MACAU||The Nasdaq Stock Market LLC|
|Class A ordinary shares, par value $0.0001 per share||MACA||The Nasdaq Stock Market LLC|
|Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50||MACAW||The Nasdaq Stock Market LLC|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
Amendment to Business Combination Agreement
On August 17, 2022, Moringa Acquisition Corp (“Moringa”) entered into Amendment No. 1 (the “Amendment”) to the Business Combination Agreement (the “Agreement”), dated June 9, 2022, by and among Moringa, Holisto Ltd., a company organized under the laws of the State of Israel (“Holisto”), and Holisto MergerSub, Inc., a Cayman Islands exempted company and wholly-owned subsidiary of Holisto (“Merger Sub”).
The Amendment amends the Agreement in the following ways: (1) it extends the Outside Date under the Agreement from November 15, 2022 to January 1, 2023; and (2) it extends the date upon which a registration statement on Form F-4 in respect of the business combination under the Agreement (the “Registration Statement”) must be filed by Holisto with the Securities and Exchange Commission (the “SEC”) from 10 weeks from June 9, 2022 to thirteen weeks from such date.
Under Section 7.1 of the Agreement, either Moringa or Holisto may terminate the Agreement upon written notice to the other party if the Business Combination is not consummated on or before the Outside Date. Moreover, pursuant to Section 5.10(a) of the Agreement, Holisto is required to file the Registration Statement with the SEC by no later than thirteen weeks from June 9, 2022. Sections 7.1(g) and 7.4 of the Agreement also provide that if the Registration Statement has not been filed with the SEC by the specified date, Moringa may (1) terminate the Agreement by written notice to Holisto and (2) receive a Special Fee in an amount of US$3 million.
A copy of the Amendment is attached hereto as Exhibit 10.1.
Item 8.01 Other Events.
On August 17, 2022, Moringa and Holisto mutually agreed to amend the Agreement in order to extend certain deadlines, as described in Item 1.01 above, which description is incorporated by reference in this Item 8.01.
Item 9.01 Financial Statements and Exhibits.
|Amendment No. 1, dated as of August 17, 2022, to Business Combination Agreement, dated as of June 9, 2022, by and among Moringa Acquisition Corp, Holisto Ltd., and Holisto MergerSub, Inc.|
|104||Cover Page Interactive Data File (embedded within the Inline XBRL document)|
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 17, 2022
|MORINGA ACQUISITION CORP|
|By:||/s/ Gil Maman|
|Title:||Chief Financial Officer|
FIRST AMENDMENT TO THE BUSINESS COMBINATION AGREEMENT
This First Amendment the Business Combination Agreement (the “Amendment”) is made as of August 17, 2022, by and among: (i) Holisto Ltd., an Israeli company (the “Company”); (ii) Holisto MergerSub, Inc., a Cayman Islands exempted company and wholly-owned subsidiary of the Company (“Merger Sub”), and (iii) Moringa Acquisition Corp, a Cayman Islands exempted company (“Moringa”).
WHEREAS, the Company, Merger Sub and Moringa have entered into that certain Business Combination Agreement dated June 9, 2022 (the “Agreement”); and
WHEREAS, the Parties wish to amend certain terms of the Agreement as provided herein, effective as of the date hereof.
NOW, THEREFORE, in consideration of the mutual promises hereinafter contained, the Parties hereto agree as follows:
|1.||Sections 5.10(a), 7.1(g) and 7.4 of the Agreement are hereby amended such that any reference therein to ten (10) weeks from the date of the Agreement is hereby replaced with thirteen (13) weeks from the date of the Agreement.|
|2.||The reference to “November 15, 2022” shall be replaced by “January 1, 2023” in the definition of “Outside Date” in Section 7.1(b) of the Agreement.|
|3.||This Amendment forms an integral part of the Agreement. Any capitalized terms used in this Amendment not otherwise defined shall have the meaning set forth in the Agreement. Except as amended by this Amendment, all other terms and conditions of the Agreement remain in full force and effect and shall apply, mutatis mutandis, to this Amendment.|
|4.||In the event of any conflict, contradiction or inconsistency between this Amendment and the Agreement, the terms of this Amendment shall prevail.|
[Signature Page Follows]
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be signed and delivered by its respective duly authorized officer as of the date first written above.
|MORINGA ACQUISITION CORP|
|By:||/s/ Ilan Levin|
|By:||/s/ Eran Shust|
|HOLISTO MERGERSUB, INC.|
|By:||/s/ Eran Shust|
- Wall Street closes in on third straight quarterly loss
- Nike (NKE) Drops 9% as Inventory Surges 44%, Analysts See Attractive Valuation
- Hollywood Super Agent Attempts to Open Door for Twitter-Musk Settlement - Bloomberg
- Dollar gains on euro after inflation data, sterling falls
- Micron Gains Despite a Big Guidance Miss, One Analyst Upgrades While Another Assigns a New Street Low PT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Canaccord Genuity Starts CyberArk Software (CYBR) at Buy
- Altria's (MO) Move to End Noncompete Agreement 'Makes Sense'
- Titan Machinery (TITN) Announces Appointment of Bo Larsen as Chief Financial Officer
Create E-mail Alert Related CategoriesSEC Filings
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!